The FINANCIAL -- QVA149 significantly reduced the rate of all COPD exacerbations versus glycopyrronium 50 mcg and open-label (OL) tiotropium 18 mcg showed new data from the Novartis AG, a Swiss multinational pharmaceutical company.

The FINANCIAL -- GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism.

The FINANCIAL -- Beginning an international scientific and regulatory conference takes place in MOSCOW to enhance regulation of biotherapeutic medicines.

The FINANCIAL -- Eli Lilly and Company announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, will undergo scheduled surgery for a dilated aorta on Monday, May 13, 2013.

The FINANCIAL -- Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), announced that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the SEDASYS System, the first computer-assisted personalized sedation (CAPS) system.